Narrow search
Showing 1 - 10 of 985
Cover Image
The effect of intellectual property rights on domestic innovation in the pharmaceutical sector
Gamba, Simona - 2016
This paper analyses the causal impact of Intellectual Property Rights (IPR) on pharmaceutical innovation in a panel of …. Domestic innovation is measured as citation-weighted domestic patents filed at the European Patent Office (EPO): to account for … to patent at the EPO. Results show that, in the short-run, IPR stimulate innovation. The effect for developing countries …
Persistent link: https://www.econbiz.de/10011509446
Cover Image
Foreign competition and domestic innovation : evidence from U.S. patents
Autor, David H.; Dorn, David; Hanson, Gordon H.; … - 2019
emanating from China's economic ascent could in theory either augment or stifle U.S. innovation. Using three decades of U ….S. patents matched to corporate owners, we quantify how foreign competition affects domestic innovation. Rising import exposure …
Persistent link: https://www.econbiz.de/10012105572
Cover Image
The patent buyout price for Human Papilloma Virus (HPV) vaccine and the ratio of R&D costs to the patent value
Songane, Mario; Grossmann, Volker - 2020
HPV vaccination rates while keeping innovation incentives. We estimate the global patent buyout price as the present …
Persistent link: https://www.econbiz.de/10012260843
Cover Image
The economics of pending patents
Koenen, Johannes; Peitz, Martin - 2011
; pending patents ; innovation ; patent office overload ; patent inspection ; grant delays …
Persistent link: https://www.econbiz.de/10009383554
Cover Image
Does cost sharing really reduce inappropriate prescriptions?
Costa-Font, Joan; Gemmill-Toyama, Marin - 2010
This paper explores different empirical strategies to examine the effect of cost sharing for prescription drugs in some dimensions of medication-related quality, namely the probability of inappropriate prescription drug use among United States seniors. Using data from 1996 to 2005, we explore...
Persistent link: https://www.econbiz.de/10003951612
Cover Image
Push-me pull-you : comparative advertising in the OTC analgesics industry
Anderson, Simon P.; Ciliberto, Federico; Liaukonyte, Jura; … - 2015
We derive equilibrium incentives to use comparative advertising that pushes up own brand perception and pulls down the brand image of targeted rivals. Data on content and spending for all TV advertisements in OTC analgesics enable us to construct matrices of dollar rival targeting and estimate...
Persistent link: https://www.econbiz.de/10011286486
Cover Image
Explaining vaccine hesitancy : a Covid-19 study of the United States
Goel, Rajeev K.; Saunoris, James W. - 2022
Using recent data on the unvaccinated across U.S. states, this paper focuses on the determinants of vaccine hesitancy related to the COVID-19 pandemic. Results show that more prosperous states and states with more elderly and physicians have lower vaccine hesitancy. There was some evidence of...
Persistent link: https://www.econbiz.de/10013168039
Cover Image
Drivers of Covid-19 vaccinations : vaccine administration and delivery efficiency in the United States
Goel, Rajeev K.; Nelson, Michael A. - 2021
This paper adds some formal research to the success of ongoing efforts to combat the COVID-19 pandemic by examining the drivers of the administration and delivery efficiency of coronavirus vaccines. For this purpose, we use data from the 50 US states and place the formal analysis in the context...
Persistent link: https://www.econbiz.de/10012494792
Cover Image
How cost effective are new cancer drugs in the U.S.?
Lichtenberg, Frank R. - 2017
. Moreover, cancer drug innovation has been accelerating: more than 8 times as many new cancer drugs were approved during 2005 …
Persistent link: https://www.econbiz.de/10011735934
Cover Image
Give me your best shot! : diffusion of complete versus booster Covid-19 vaccines across US counties
Goel, Rajeev K.; Nelson, Michael A. - 2023
This paper compares drivers of full COVID-19 vaccinations and booster doses across U.S. counties. Booster doses are contingent upon someone receiving the primary doses, and the risk attitudes and propensities to get vaccinated may be different across individuals, along with the supply chain...
Persistent link: https://www.econbiz.de/10014313479